育龄期子宫肌瘤异常肥大和子宫肌瘤剔除术后残留的高危因素分析
Analysis of High Risk Factors of Excessive Hypertrophy of Uterine Leiomyoma and Residual after Myomectomy in Child-Bearing Period
DOI: 10.12677/HJS.2022.113013, PDF,   
作者: 卢翠华:单县中心医院妇产科,山东 菏泽
关键词: 育龄期子宫肌瘤残留继续增长Child-Bearing Period Fibroid Residual Recrudescence
摘要: 目的:探究育龄期子宫肌瘤异常肥大和子宫肌瘤剔除术后残留的高危因素,以期为临床上育龄期子宫肌瘤患者的治疗提供思路和理论依据。方法:收集331例育龄期患者,根据是否发生子宫肌瘤的异常肥大,将患者分成异常肥大组和非异常肥大组,其中异常肥大组患者54例,非异常肥大组患者277例。其中54例育龄期子宫肌瘤异常肥大患者选择子宫肌瘤剔除术。54例子宫肌瘤异常肥大的子宫肌瘤患者均选择子宫肌瘤剔除术,根据是否有残留分成残留组和非残留组,收集入组者的基准资料,包括年龄,体重指数,病理类型。利用Logistic回归分析进行单因素和多因素分析。结果:入组的331例育龄期患者中,有54例子宫肌瘤患者出现育龄期异常肥大,育龄期后子宫肌瘤异常肥大率为16.31%。单因素分析结果显示,超重,子宫肌瘤数目 ≥ 5个,最大肌瘤直径,富于细胞型子宫肌瘤是育龄期子宫肌瘤异常肥大的高危因素(P < 0.05)。Logistic多因素分析结果显示,超重,子宫肌瘤数目 ≥ 5,病理类型是育龄期子宫肌瘤异常肥大的高危因素(P < 0.05)。54例子宫肌瘤异常肥大患者选择子宫肌瘤剔除术,有18例子宫肌瘤患者出现术后残留,肌瘤术后残留率为33.33%。单因素分析结果显示,超重,子宫肌瘤数目 ≥ 5个,最大肌瘤直径,富于细胞型子宫肌瘤是育龄期子宫肌瘤手术剔除术后残留的高危因素(P < 0.05)。Logistic多因素分析结果显示,超重,子宫肌瘤数目 ≥ 5,病理类型是育龄期子宫肌瘤手术剔除术后残留的高危因素(P < 0.05)。结论:超重,子宫肌瘤数目 ≥ 5个,最大肌瘤直径,富于细胞型子宫肌瘤是育龄期子宫肌瘤异常肥大和子宫肌瘤手术剔除术后残留的高危因素。
Abstract: Objective: To explore the high-risk factors of excessive hypertrophy of hysteromyomas and residual hysteromyoma, in order to provide ideas and theoretical basis for the clinical treatment of hysteromyoma patients in child-bearing period. Methods: The 331 patients in child-bearing period were collected. According to the growth of uterine fibroids, the patients were divided into excessive hypertrophy and non-excessive hypertrophy, including 54 patients in excessive hypertrophy and 277 patients in non-excessive hypertrophy. Among them, 54 patients with hysteromyoma excessive hypertrophy, and hysteromyomectomy was selected. All 54 patients with uterine fibroids with continuous growth of uterine fibroids were selected for myomectomy. They were divided into the residual group and the non-residual group according to whether there was residual. The baseline data of the participants were collected, including age, the body mass index (BMI), pathological type. The Logistic regression analysis was used for univariate and multivariate analysis. Results: Among the 331 patients in child-bearing period in the group, 54 patients with hysteromyoma excessive hypertrophy, and the excessive hypertrophy rate of hysteromyoma was 16.31%. The univariate analysis showed that overweight, the number of hysteromyoma ≥ 5, the maximum diameter of hysteromyomas, cell-rich hysteromyomas were the high-risk factors for the excessive hypertrophy of hyster-omyomas in child-bearing period (P < 0.05). The results of logistic multivariate analysis showed that overweight, the number of hysteromyomas ≥ 5, pathological type were the high-risk factors for the excessive hypertrophy of hysteromyomas (P < 0.05). The myomectomy was selected in 54 patients with excessive hypertrophy of hysteromyoma. 18 patients with hysteromyoma had postoperative residue, and the residual rate of hysteromyoma was 33.33%. The univariate analysis showed that overweight, the number of hysteromyomas ≥ 5, the maximum diameter of hystero-myomas, cell-rich hysteromyomas were the high-risk factors for residual after surgical removal of hysteromyomas in child-bearing period (P < 0.05). The results of logistic multivariate analysis showed that overweight, the number of hysteromyomas ≥ 5, pathological type were the high-risk factors of residual after surgical removal of hysteromyomas in child-bearing period (P < 0.05). Con-clusion: The overweight, the number of hysteromyomas ≥ 5, the maximum diameter of hysteromyomas, cell-rich hysteromyomas are the high-risk factors for the continued growth of hysteromyomas and the residue after surgical removal of hysteromyomas.
文章引用:卢翠华. 育龄期子宫肌瘤异常肥大和子宫肌瘤剔除术后残留的高危因素分析[J]. 外科, 2022, 11(3): 76-82. https://doi.org/10.12677/HJS.2022.113013

参考文献

[1] Travaglino, A., Raffone, A., Santoro, A., et al. (2021) Prognostic Significance of Atypical Mitotic Figures in Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP) of the Uterus and Uterine Adnexa. APMIS, 129, 165-169. [Google Scholar] [CrossRef] [PubMed]
[2] Shin, E.S. and Kang, H.S. (2021) Case of Suspected Torsion and Amputation of Myoma during Pregnancy. Annals of Medicine and Surgery, 71, Article No. 103007. [Google Scholar] [CrossRef] [PubMed]
[3] 沈燕, 沈冰燕. 腹腔镜下子宫动脉阻断术联合子宫肌瘤剔除术治疗子宫肌瘤的临床疗效[J]. 检验医学与临床, 2021, 18(19): 2830-2833.
[4] 吴承真. 子宫肌瘤经阴道全子宫切除术与腹式全子宫切除术的应用对比分析[J]. 时珍国医国药, 2012, 23(11): 2947-2948.
[5] 李红, 王莉. 腹腔镜下子宫肌瘤剔除术与全子宫切除术治疗围绝经期子宫肌瘤对患者卵巢功能的影响研究[J]. 贵州医药, 2021, 45(10): 1554-1555.
[6] 黄静, 吴淑梅. 子宫肌瘤腹腔镜全子宫切除术中切除和保留双侧输卵管对卵巢功能影响的随机对照研究[J]. 河南外科学杂志, 2020, 26(5): 99-101.
[7] Qin, H., Lin, Z., Vásquez, E., et al. (2021) Association between Obesity and the Risk of Uterine Fibroids: A Systematic Review and Meta-Analysis. Journal of Epidemiology and Community Health, 75, 197-204.
[8] 施兴华, 黄海燕, 张帅赛. 子宫肌瘤剔除术后残留复发的影响因素分析[J]. 中国当代医药, 2021, 28(21): 115-117.
[9] 王春松. 子宫肌瘤剔除术后残留和复发的临床危险因素分析[J]. 中国医药指南, 2016, 14(8): 155.